A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis

Author： El Kasmi K.C. Theisen D. Brons N.H.C. Ammerlaan W. Klingele M. Truong A.T. Muller C.P.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.19, 1999-05, pp. : 2436-2445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen

By Hathaway L.J. Obeid O.E. Steward M.W.

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite

C3d enhancement of neutralizing antibodies to measles hemagglutinin

By Green T.D. Newton B.R. Rota P.A. Xu Y. Robinson H.L. Ross T.M.

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 242-248

Elsevier

Access to resources Recommend Favorite

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection

By Hua S. Parnell M. Caldwell H.D.

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 1023-1032

Elsevier

Access to resources Recommend Favorite

The rationale of a peptide-conjugate vaccine against measles

By Putz M.M. Muller C.P.

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 663-666

Elsevier

Access to resources Recommend Favorite

Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998

By Khodabandeh Loo M. Sabahi F. Soleimanjdahi H. Kazemnejad A. Roustai M.H.

European Journal of Epidemiology, Vol. 18, Iss. 11, 2003-11 ,pp. : 1085-1089

Springer Publishing Company

Access to resources Recommend Favorite